06/02/2023 (Agence Europe) – On 3 February 2023, the European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMAs) launched a public consultation on the creation of a multi-stakeholder platform to improve clinical trials in the European Union. This platform is linked to the joint initiative to accelerate clinical trials in the EU ‘ACT EU’ (see EUROPE B13088A9). Participants are invited to express their views on the main work priorities and to...